Patents by Inventor Aaron Avraham NAZARIAN

Aaron Avraham NAZARIAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cannabinoid receptor-1 (CB1) monoclonal antibodies
    Patent number: 10227406
    Abstract: This disclosure relates to CB1 receptor antigen-binding proteins, e.g. antibodies and methods of using the CB1 receptor antibodies. The CB1 receptor antibodies may comprise an antagonistic antibody to CB1 receptors and may be used to treat various health conditions. The health conditions can comprise obesity or diabetes or any disease that benefits from antagonism of the CB1 receptor.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: March 12, 2019
    Assignee: AMGEN, INC
    Inventors: Peter Coward, Steven A. Moore, Jr., Shi-Yuan Meng, Mei-Mei Tsai, Chadwick Terence King, Aaron Avraham Nazarian
  • CB-1 RECEPTOR ANTIGEN-BINDING PROTEINS AND USES THEREOF
    Publication number: 20160145333
    Abstract: This disclosure relates to CB1 receptor antigen-binding proteins, e.g. antibodies and methods of using the CB1 receptor antibodies. The CB1 receptor antibodies may comprise an antagonistic antibody to CB1 receptors and may be used to treat various health conditions. The health conditions can comprise obesity or diabetes or any disease that benefits from antagonism of the CB1 receptor.
    Type: Application
    Filed: June 25, 2014
    Publication date: May 26, 2016
    Applicant: AMGEN INC.
    Inventors: Peter COWARD, Steven A. MOORE, Jr., Shi-Yuan MENG, Mei-Mei TSAI, Chadwick Terence KING, Aaron Avraham NAZARIAN